16 operations-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"https:" positions at Amsterdam UMC
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
compound influences bone remodelling and fracture healing in the OI-BBoC model. Your work aims to demonstrate that this human organ-on-chip platform can serve as a reliable measurement model to understand OI
-
expertise. Together, we work towards improving our understanding of neurodegenerative diseases and ultimately contributing to better patient care. Amsterdam UMC Research BV Amsterdam UMC Research BV supports
-
emerging from other POLARIS work packages. By aligning preclinical readouts with clinically relevant endpoints, your work will contribute to the translational value of leukodystrophy models. You will work
-
will work in Dr Fleur Tjong’s group (TjongLab) embedded in the Amsterdam Center for Computational Cardiology under co-supervision prof. dr. Folkert Asselbergs at Amsterdam UMC, location AMC. Our
-
embedded within the Quantitative Healthcare Analysis (qurAI) group and conducted in close collaboration with the CARA Lab and clinical partners in the Netherlands and abroad. You will work with large, multi
-
sequencing. Your work will directly contribute to the development of new treatment strategies for patients with lung cancer and mesothelioma. As a Research Technician, you will play an important role in
-
through to preclinical characterisation. Your work will include: Selecting GPRC5B-targeting nanobodies from immune and synthetic nanobody libraries and evaluating AI-generated candidates. Characterising
-
Hospital Tübingen (Eberhard Karls University of Tübingen), Germany. You will be embedded in the POLARIS consortium and work with experts in leukodystrophy, paediatric neurology, developmental psychopathology
-
of liquid biomarkers for leukodystrophies. You will work with iPSC-derived disease models and patient samples, generate and analyse multi-omics data, and help identify biomarkers that can support diagnosis
-
and its potential as a therapeutic target. Your work will include: Developing cell-based bioluminescent and fluorescent biosensor assays to detect GPCR signalling events in different cellular models